What is WellDoc?
WellDoc operates at the forefront of digital health, developing a comprehensive chronic care platform designed to empower individuals living with long-term health issues. The company's technology provides multi-condition support, addressing critical areas such as diabetes, hypertension, heart failure, and behavioral health. By delivering actionable insights directly into users' daily routines, WellDoc aims to significantly improve health outcomes and enhance the overall quality of life for its patient base. This strategic approach positions WellDoc as a key player in the evolving landscape of personalized healthcare solutions.
How much funding has WellDoc raised?
WellDoc has raised a total of $56.3M across 6 funding rounds:
Private Equity
$1M
Private Equity
$8.4M
Series A
$20M
Private Equity
$4.5M
Series B
$22M
Debt
$350K
Private Equity (2006): $1M, investors not publicly disclosed
Private Equity (2012): $8.4M, investors not publicly disclosed
Series A (2014): $20M supported by TCP Venture Capital, Windham Venture Partners, and Merck Global Health Innovation Fund
Private Equity (2014): $4.5M, investors not publicly disclosed
Series B (2015): $22M backed by Excel Venture Management, Hudson River Capital Partners, Samsung Ventures, Alexandria Venture Investments, and Adage Capital Management
Debt (2020): $350K with participation from PPP
Key Investors in WellDoc
TCP Venture Capital
TCP Venture Capital is an early-stage venture capital firm based in Baltimore, Maryland, focusing on unique technology applications. They partner with entrepreneurs to build high-growth technology companies, particularly those committed to headquartering in Baltimore City.
Windham Venture Partners
Windham Venture Partners is a New York City based venture capital firm focused on healthcare, with particular emphasis on medical technology and digital health. They have a small, highly focused team of managers who enjoy close relationships with strategics, leading venture capital firms, and innovators and entrepreneurs in the healthcare industry.
Merck Global Health Innovation Fund
The Merck Global Health Innovation Fund is an investment arm of Merck, a global healthcare company. They focus on investing in companies that develop innovative solutions to improve health outcomes and advance healthcare delivery.
What's next for WellDoc?
The recent major strategic investment signals a new phase of expansion and development for WellDoc. This capital infusion is expected to fuel further innovation within its chronic care platform, potentially broadening its condition management capabilities and enhancing its data analytics for more personalized patient interventions. The company is likely to focus on scaling its operations, expanding its market reach, and forging new partnerships within the healthcare ecosystem. This strategic backing will be instrumental in solidifying WellDoc's position as a leader in digital health and chronic disease management.
See full WellDoc company page
